Noble James

Noble James is listed in filings as Director at LAVA Therapeutics N.V.. This profile follows SEC Form 4 activity through Nov 17, 2025, including 2 public disclosures. Recent filings connect the profile to LAVA Therapeutics N.V. (LVTX). The current snapshot covers public activity from Feb 18, 2025 to Nov 17, 2025. Reported amounts are shown as $31.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.